Characteristic CSF Prion Seeding Efficiency in Humans with Prion Diseases

Molecular Neurobiology

Volumn 51, Issue 1, 2015, Pages 396-405

  Cramm, Maria ^a   Schmitz, Matthias ^a   Karch, André ^a   Zafar, Saima ^a   Varges, Daniela ^a   Mitrova, Eva ^b   Schroeder, Bjoern ^c   Raeber, Alex ^c   Kuhn, Franziska ^c   Zerr, Inga ^a  

^a UNIVERSITY MEDICAL CENTER GÖTTINGEN   (Germany)

^b SLOVAK MEDICAL UNIVERSITY   (Slovakia)

^c Prionics AG   (Switzerland)

Author keywords

Cerebrospinal fluid; Creutzfeldt Jakob disease; Premortem test; Prion protein; Real time quaking induced conversion assay

Indexed keywords

CODON; PRION;

ADULT; AGED; BIOASSAY; BOVINE SPONGIFORM ENCEPHALOPATHY; CEREBROSPINAL FLUID; CODON; CREUTZFELDT JAKOB DISEASE; FATAL FAMILIAL INSOMNIA; FEMALE; GENETICS; GENOTYPE; HUMAN; LUMBAR PUNCTURE; MALE; METABOLISM; MIDDLE AGED; NERVE CELL; ONSET AGE; PATHOLOGY; PRION; PRION DISEASE; TIME FACTOR; VERY ELDERLY; YOUNG ADULT;

ADULT; AGE OF ONSET; AGED; AGED, 80 AND OVER; CODON; CREUTZFELDT-JAKOB SYNDROME; ENCEPHALOPATHY, BOVINE SPONGIFORM; ENDPOINT DETERMINATION; FEMALE; GENOTYPE; HUMANS; INSOMNIA, FATAL FAMILIAL; MALE; MIDDLE AGED; NEURONS; PRION DISEASES; PRIONS; SPINAL PUNCTURE; TIME FACTORS; YOUNG ADULT;

EID: 84925328892     PISSN: 08937648     EISSN: 15591182     Source Type: Journal    
DOI: 10.1007/s12035-014-8709-6     Document Type: Article

References (32)

1. Parchi P, Giese A, Capellari S et al (1999) Classification of sporadic Creutzfeldt-Jakob disease based on molecular and phenotypic analysis of 300 subjects. Ann Neurol 42:224–233
2. Cali I, Castellani R, Yuan J, Al-Shekhlee A, Cohen ML, Xiao X, Moleres FJ, Parchi P, Zou WQ, Gambetti P (2006) Classification of sporadic Creutzfeldt-Jakob disease revisited. Brain 129:2266–2277
3. Bishop MT, Will RG, Manson JC (2010) Defining sporadic Creutzfeldt-Jakob disease strains and their transmission properties. Proc Natl Acad Sci USA 107:12005–12010
4. Gambetti P, Kong Q, Zou W, Parchi P, Chen SG (2003) Sporadic and familial CJD: classification and characterization. Br Med Bull 66:213–239
5. Hsiao K, Meiner Z, Kahana E, Cass C, Kahana I, Avrahami D, Scarlato G, Abramsky O, Prusiner SB, Gabizon R (1991) Mutation of the prion protein in Libyan Jews with Creutzfeldt- Jakob disease. N Engl J Med 324:1091–1097
6. Kovács GG, Puopolo M, Ladogana A, Pocchiari M, Budka H et al (2005) Genetic prion disease: the EUROCJD experience. Hum Genet 118:166–174
7. Krasnianski A, Bartl M, Sanchez Juan PJ, Heinemann U, Meissner B, Varges D, Schulze-Sturm U, Kretzschmar HA, Schulz-Schaeffer WJ, Zerr I (2008) Fatal familial insomnia: clinical features and early identification. Ann Neurol 63:658–661
8. Atarashi R, Satoh K, Sano K et al (2011) Ultrasensitive human prion detection in cerebrospinal fluid by real-time quaking-induced conversion. Nature Medicine 17:175–178
9. McGuire LI, Peden AH, Orrú CD, Wilham JM, Appleford NE, Mallinson G, Andrews M, Head MW, Caughey B, Will RG, Knight RS, Green AJ (2012) Real time quaking-induced conversion analysis of cerebrospinal fluid in sporadic Creutzfeldt-Jakob disease. Ann Neurol 2:278–285
10. Atarashi R, Wilham JM, Christensen L et al (2003) Simplified ultrasensitive detection of recombinant PrP conversion with shaking. Nat Methods 5:211–212
11. Orru CD, Wilham JM, Raymond LD, Kuhn F, Schroeder B, Raeber AJ, Caughey B (2011) Prion disease blood test using immunoprecipitation and improved quaking induced conversion. MBio 2:e00078–11
12. Orru CD, Wilham JM, Hughson AG et al (2009) Human variant CJD and sheep scrapie PrPres detection using seeded conversion of recombinant prion protein. Protein Eng Des Sel 22:515–521
13. Report of a WHO consultation on global surveillance, diagnosis and therapy of human transmissible spongiform encephalopathies (1998). Geneva, Switzerland: World Health Organization
14. Zerr I, Kallenberg K, Summers DM et al (2009) Updated clinical diagnostic criteria for sporadic Creutzfeldt-Jakob disease. Brain 132:2659–2668
15. Zerr I, Pocchiari M, Collins S, Brandel JP, de Pedro Cuesta J et al (2000) Analysis of EEG and CSF 14-3-3 proteins as aids to the diagnosis of Creutzfeldt-Jakob disease. Neurology 55:811–815
16. Windl O, Giese A, Schulz-Schaeffer W, Zerr I, Skworc K, Arendt S, Oberdieck C, Bodemer M, Poser S, Kretzschmar HA (1999) Molecular genetics of human prion disease in Germany. Hum Genet 105:244–252
17. Wilham JM, Orrú CD, Bessen RA, Atarashi R, Sano K, Race B, Meade-White KD, Taubner LM, Timmes A, Caughey B (2010) Rapid end-point quantitation of prion seeding activity with sensitivity comparable to bioassays. PLoS Pathog 6:e1001217
18. Sano K, Satoh K, Atarashi R, Takashima H, Iwasaki Y, Yoshida M, Sanjo N, Murai H, Mizusawa H, Schmitz M, Zerr I, Kim YS, Nishida N (2013) Early detection of abnormal prion protein in genetic human prion diseases now possible using real-time QUIC assay. PLoS One 8:e54915
19. Levy Y, Becker OM (2002) Conformational polymorphism of wild-type and mutant prion proteins: energy landscape analysis. Proteins 47:458–468
20. Capellari S, Parchi P, Russo CM, Sanford J, Sy MS, Gambetti P, Petersen RB (2000) Effect of the E200K mutation on prion protein metabolism. Comparative study of a cell model and human brain. Am J Pathol 157:613–622
21. Rossetti G, Giachin G, Legname G, Carloni P (2010) Structural facets of disease-linked human prion protein mutants: a molecular dynamic study Proteins 78:3270–3280
22. Hill AF, Joiner S, Beck JA, Campbell TA, Dickinson A, Poulter M, Wadsworth JD, Collinge J (2006) Distinct glycoforms ratios of protease resistant prion protein associated with PRNP point mutations. Brain 129:676–685
23. Gao C, Ren K, Li LZ, Jiang HY, Chen C, Zhang J, Han J, Dong XP (2012) Mutant D178N prion protein converts spontaneously in RT-QuIC assay. Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi 26:370–373
24. Jackson WS, Borkowski AW, Faas H, Steele AD, King OD et al (2009) Spontaneous generation of prion infectivity in fatal familial insomnia knockin mice. Neuron 63:438–450
25. Tateishi J, Brown P, Kitamoto T, Hoque ZM, Roos R, Wollman R, Cervenáková L, Gajdusek DC (1995) First experimental transmission of fatal familial insomnia. Nature 376:434–435
26. Asante EA, Gowland I, Grimshaw A, Linehan JM, Smidak M, Houghton R, Osiguwa O, Tomlinson A, Joiner S, Brandner S, Wadsworth JD, Collinge J (2009) Absence of spontaneous disease and comparative prion susceptibility of transgenic mice expressing mutant human prion proteins. J Gen Virol 90:546–558
27. Friedman-Levi Y, Meiner Z, Canello T, Frid K, Kovacs GG, Budka H, Avrahami D, Gabizon R (2011) Fatal prion disease in a mouse model of genetic E200K Creutzfeldt-Jakob Disease. PLoS Pathog 7:e1002350
28. Hill AF, Joiner S, Wadsworth JD, Sidle KC, Bell JE, Budka H, Ironside JW, Collinge J (2003) Molecular classification of sporadic Creutzfeldt-Jakob disease. Brain 126:1333–1346
29. Uro-Coste E, Cassard H, Simon S, Lugan S, Bilheude J, Perret-Liaudet A, Ironside JW, Haik S, Basset-Leobon C, Lacroux C, Peoch’ K, Streichenberger N et al (2008) Beyond PrP9res type 1/type 2 dichotomy in Creutzfeldt-Jakob disease. PLoS Pathog 4:e1000029
30. Alperovitch A, Zerr I, Pocchiari M, Mitrova E, de Pedro Cuesta J, Hegyi I, Collins S, Kretzschmar H, van Duijn C, Will RG (1999) Codon 129 prion protein genotype and sporadic Creutzfeldt-Jakob disease. Lancet 353:1673–1674
31. Peden AH, McGuire LI, Appleford NE, Mallinson G, Wilham JM, Orrú CD, Caughey B, Ironside JW, Knight RS, Will RG, Green AJ, Head MW (2012) Sensitive and specific detection of sporadic Creutzfeldt-Jakob disease brain prion protein using real-time quaking-induced conversion. J Gen Virol 93:438–449
32. Mitrová E, Belay G (2009) Creutzfeldt-Jakob disease with E200K mutation in Slovakia: characterization and development. Acta Virol 46:31–39